Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker ACAD
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 4, 2026 | ACAD ACADIA Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 23, 2026 | ACAD ACADIA Pharmaceuticals Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Sep 24, 2026 | ACAD ACADIA Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 24, 2026 | ACAD ACADIA Pharmaceuticals Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 11, 2026 | ACAD ACADIA Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 4, 2026 | ACAD ACADIA Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 29, 2026 | ACAD ACADIA Pharmaceuticals Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 29, 2026 | ACAD ACADIA Pharmaceuticals Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 6, 2026 | ACAD ACADIA Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 1, 2026 | ACAD ACADIA Pharmaceuticals Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 1, 2026 | ACAD ACADIA Pharmaceuticals Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Mar 5, 2026 | ACAD ACADIA Pharmaceuticals Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Feb 25, 2026 | ACAD ACADIA Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 13, 2026 | ACAD ACADIA Pharmaceuticals Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 13, 2026 | ACAD ACADIA Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 5, 2025 | ACAD ACADIA Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 3, 2025 | ACAD ACADIA Pharmaceuticals Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 6, 2025 | ACAD ACADIA Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 10, 2025 | ACAD ACADIA Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 29, 2025 | ACAD ACADIA Pharmaceuticals Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 20, 2025 | ACAD ACADIA Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 20, 2025 | ACAD ACADIA Pharmaceuticals Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| May 7, 2025 | ACAD ACADIA Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 16, 2025 | ACAD ACADIA Pharmaceuticals Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Feb 26, 2025 | ACAD ACADIA Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 11, 2024 | ACAD ACADIA Pharmaceuticals Inc. | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| Nov 20, 2024 | ACAD ACADIA Pharmaceuticals Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 6, 2024 | ACAD ACADIA Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
28 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:43 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances